News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
640,119 Results
Type
Article (37663)
Company Profile (121)
Press Release (602324)
Multimedia
Podcasts (65)
Webinars (11)
Section
Business (172638)
Career Advice (2766)
Deals (32388)
Drug Delivery (94)
Drug Development (72660)
Employer Resources (159)
FDA (15728)
Job Trends (14592)
News (300362)
Policy (29012)
Tag
Academia (2669)
Academic (1)
Accelerated approval (22)
Adcomms (27)
Allergies (131)
Alliances (43317)
ALS (163)
Alzheimer's disease (1664)
Antibody-drug conjugate (ADC) (255)
Approvals (15955)
Artificial intelligence (468)
Autoimmune disease (122)
Automation (31)
Bankruptcy (289)
Best Places to Work (12092)
BIOSECURE Act (18)
Biosimilars (169)
Biotechnology (84)
Bladder cancer (148)
Brain cancer (53)
Breast cancer (595)
Cancer (4427)
Cardiovascular disease (355)
Career advice (2310)
Career pathing (37)
CAR-T (266)
CDC (40)
Celiac Disease (1)
Cell therapy (709)
Cervical cancer (34)
Clinical research (62305)
Collaboration (1510)
Company closure (3)
Compensation (1054)
Complete response letters (45)
COVID-19 (2568)
CRISPR (86)
C-suite (728)
Cystic fibrosis (143)
Data (5828)
Decentralized trials (1)
Denatured (14)
Depression (112)
Diabetes (449)
Diagnostics (6856)
Digital health (38)
Diversity (6)
Diversity, equity & inclusion (39)
Drug discovery (217)
Drug pricing (141)
Drug shortages (21)
Duchenne muscular dystrophy (200)
Earnings (71466)
Editorial (53)
Employer branding (21)
Employer resources (143)
Events (106897)
Executive appointments (991)
FDA (18535)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (21)
Funding (1351)
Gene editing (185)
Generative AI (36)
Gene therapy (537)
GLP-1 (805)
Government (4219)
Grass and pollen (7)
Guidances (374)
Healthcare (19876)
HIV (47)
Huntington's disease (39)
IgA nephropathy (73)
Immunology and inflammation (212)
Immuno-oncology (32)
Indications (77)
Infectious disease (2812)
Inflammatory bowel disease (185)
Inflation Reduction Act (11)
Influenza (104)
Intellectual property (217)
Interviews (546)
IPO (16280)
IRA (39)
Job creations (2871)
Job search strategy (1896)
Kidney cancer (17)
Labor market (63)
Layoffs (493)
Leadership (36)
Legal (6395)
Liver cancer (79)
Longevity (12)
Lung cancer (594)
Lymphoma (344)
Machine learning (38)
Management (60)
Manufacturing (653)
MASH (156)
Medical device (14326)
Medtech (14366)
Mergers & acquisitions (17174)
Metabolic disorders (1066)
Multiple sclerosis (140)
NASH (13)
Neurodegenerative disease (287)
Neuropsychiatric disorders (69)
Neuroscience (2762)
NextGen: Class of 2025 (6714)
Non-profit (4847)
Now hiring (49)
Obesity (451)
Opinion (272)
Ovarian cancer (151)
Pain (185)
Pancreatic cancer (195)
Parkinson's disease (267)
Partnered (30)
Patents (444)
Patient recruitment (409)
Peanut (57)
People (52932)
Pharmaceutical (32)
Pharmacy benefit managers (25)
Phase I (19437)
Phase II (27622)
Phase III (20615)
Pipeline (3862)
Policy (234)
Postmarket research (2018)
Preclinical (8006)
Press Release (62)
Prostate cancer (215)
Psychedelics (41)
Radiopharmaceuticals (274)
Rare diseases (732)
Real estate (4932)
Recruiting (67)
Regulatory (22196)
Reports (31)
Research institute (2493)
Resumes & cover letters (451)
Rett syndrome (23)
RNA editing (10)
RSV (73)
Schizophrenia (135)
Series A (217)
Series B (167)
Service/supplier (6)
Sickle cell disease (98)
Special edition (17)
Spinal muscular atrophy (152)
Sponsored (32)
Startups (3056)
State (2)
Stomach cancer (9)
Supply chain (92)
Tariffs (69)
The Weekly (50)
Vaccines (884)
Venture capital (66)
Weight loss (276)
Women's health (63)
Worklife (19)
Date
Today (110)
Last 7 days (551)
Last 30 days (2452)
Last 365 days (31244)
2025 (30758)
2024 (35954)
2023 (41286)
2022 (52116)
2021 (57039)
2020 (55564)
2019 (48730)
2018 (36627)
2017 (32100)
2016 (30368)
2015 (35472)
2014 (24629)
2013 (19205)
2012 (20726)
2011 (21532)
2010 (18623)
Location
Africa (775)
Alabama (83)
Alaska (7)
Arizona (215)
Arkansas (12)
Asia (37320)
Australia (6626)
California (10590)
Canada (3127)
China (1000)
Colorado (443)
Connecticut (465)
Delaware (314)
Europe (86704)
Florida (1567)
Georgia (347)
Hawaii (2)
Idaho (61)
Illinois (805)
India (54)
Indiana (506)
Iowa (20)
Japan (371)
Kansas (121)
Kentucky (39)
Louisiana (24)
Maine (81)
Maryland (1314)
Massachusetts (7817)
Michigan (325)
Minnesota (605)
Mississippi (5)
Missouri (132)
Montana (33)
Nebraska (26)
Nevada (117)
New Hampshire (79)
New Jersey (2888)
New Mexico (30)
New York (2831)
North Carolina (1434)
North Dakota (10)
Northern California (5095)
Ohio (319)
Oklahoma (21)
Oregon (39)
Pennsylvania (2168)
Puerto Rico (19)
Rhode Island (45)
South America (1085)
South Carolina (59)
South Dakota (1)
Southern California (4139)
Tennessee (164)
Texas (1641)
United States (38188)
Utah (324)
Vermont (1)
Virginia (253)
Washington D.C. (74)
Washington State (881)
West Virginia (3)
Wisconsin (104)
Wyoming (2)
640,119 Results for "recipharm ab".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers
December 16, 2025
·
9 min read
Press Releases
Biovica International AB - Q2 Interim report Aug - Oct 2025
December 18, 2025
·
7 min read
Press Releases
Recipharm and PLG announce strategic partnership to accelerate development projects
May 13, 2025
·
4 min read
Press Releases
Bulletin from The Extraordinary General Meeting in Alligator Bioscience AB
November 25, 2025
·
7 min read
Press Releases
AB Science provides intitial Phase 1 data for the combination of AB8939 with venetoclax for the treatment of refractory or relapsed acute myeloid leukemia
October 17, 2025
·
12 min read
Press Releases
BioInvent International AB: Interim Report January - September 2025
October 29, 2025
·
3 min read
Press Releases
Nomination Committee Appointed in Respect of AGM 2026 in Alligator Bioscience AB
November 4, 2025
·
3 min read
Press Releases
Notice of Extraordinary General Meeting in Alligator Bioscience AB
October 22, 2025
·
20 min read
Press Releases
AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
December 12, 2025
·
7 min read
Press Releases
Actio Biosciences Announces Preclinical Data Highlighting Ability of ABS-1230 to Potently and Selectively Inhibit KCNT1 and Significantly Reduce Seizure Activity
December 8, 2025
·
4 min read
1 of 64,012
Next
